[Federal Register Volume 85, Number 46 (Monday, March 9, 2020)]
[Notices]
[Pages 13650-13651]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04727]
[[Page 13650]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-1027; Docket No. CDC-2020-0026]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Generic Clearance for the
Collection of Qualitative Feedback on Agency Service Delivery. This
data collection is designed to garner qualitative customer and
stakeholder feedback in an efficient, timely manner, in accordance with
the Administration's commitment to improving service delivery.
DATES: CDC must receive written comments on or before May 8, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0026 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
Generic Clearance for the Collection of Qualitative Feedback on
Agency Service Delivery (OMB Control No. 0920-1027, Exp. 7/31/2020)--
Revision--National Center for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP). Centers for Disease Control and Prevention (CDC)
Background and Brief Description
CDC is requesting a three-year revision to Generic Clearance for
the Collection of Qualitative Feedback on Agency Service Delivery (OMB
Control No. 0920-1027, Exp. 7/31/2020). During the past three-year
approval period, seven GenICs consisting of 13,574 respondents were
submitted for review and approval. The collections included web-based
surveys, focus groups, and program assessments. The information
collection activities conducted under this revision will continue to
garner qualitative customer and stakeholder feedback in an efficient,
timely manner, in accordance with the Administration's commitment to
improving service delivery.
Qualitative feedback is information that provides useful insights
on perceptions and opinions, but are not statistical surveys that yield
quantitative results that can be generalized to the population of
study. This feedback will provide insights into customer or stakeholder
perceptions, experiences and expectations, provide an early warning of
issues with service, or focus attention on areas where communication,
training, or changes in operations might improve delivery of products
or services. These collections will allow for ongoing, collaborative,
and actionable communications between the Agency and its customers and
stakeholders. It will also allow feedback to contribute directly to the
improvement of program management.
This type of generic clearance for qualitative information will not
be used for quantitative information collections that are designed to
yield reliably actionable results, such as monitoring trends over time
or documenting program performance. Such data uses require more
rigorous designs that address: The target population to which
generalizations will be made, the sampling frame, the sample design
(including stratification and clustering), the precision requirements
or power calculations that justify the proposed sample size, the
expected response rate, methods for assessing potential non-response
bias, the protocols for data collection, and any testing procedures
that were or will be undertaken prior fielding the study. Depending on
the degree of influence the results are likely to have, such
collections may still be eligible for submission for other generic
mechanisms that are designed to yield quantitative results.
Respondents will be screened and selected from individuals and
households, businesses, organizations, and/or State, Local or Tribal
Governments. Below we provide CDC's projected annualized estimate for
the next three years. There is no cost to respondents other than their
time. The estimated annualized burden hours for this data collection
activity are 9,690.
[[Page 13651]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Annual
Type of collection Number of frequency per Hours per Total hours
respondents response response
----------------------------------------------------------------------------------------------------------------
Online surveys.................................. 10,500 1 30/60 5,250
Discussion Groups............................... 280 1 2 560
Focus groups.................................... 640 1 2 1,280
Website/app usability testing................... 2,000 1 30/60 1,000
Interviews...................................... 800 1 2 1,600
---------------------------------------------------------------
Total....................................... .............. .............. .............. 9,690
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-04727 Filed 3-6-20; 8:45 am]
BILLING CODE 4163-18-P